Edition:
United States

Aileron Therapeutics Inc (ALRN.OQ)

ALRN.OQ on NASDAQ Stock Exchange Global Market

9.87USD
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
$9.87
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
13,571
52-wk High
$15.34
52-wk Low
$9.67

Chart for

About

Aileron Therapeutics, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing a class of therapeutics called stapled peptides. It is also developing a pipeline of stapled peptide drugs across a range of therapeutic areas, including cancer, endocrine and... (more)

Overall

Beta: --
Market Cap(Mil.): $145.24
Shares Outstanding(Mil.): 14.71
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 185.97 15.71
EPS (TTM): -- -- --
ROI: -- -11.84 31.93
ROE: -- -36.93 16.16

BRIEF-Aileron Therapeutics posts Q3 loss of $0.45 per share

* Aileron therapeutics reports third quarter 2017 financial results

Nov 09 2017

BRIEF-Aileron Therapeutics reports second quarter 2017 financial results

* Aileron Therapeutics reports second quarter 2017 financial results

Aug 10 2017

BRIEF-Aileron Therapeutics prices IPO at $15 per share

* Aileron therapeutics announces pricing of initial public offering

Jun 29 2017

BRIEF-Aileron Therapeutics appoints Donald Dougherty as CFO

* Aileron Therapeutics appoints Donald Dougherty as senior vice president and chief financial officer

Jun 15 2017

Earnings vs. Estimates